Reuters logo
Vivus signs $300 mln deal with Auxilium for erectile dysfunction drug
October 11, 2013 / 11:21 AM / 4 years ago

Vivus signs $300 mln deal with Auxilium for erectile dysfunction drug

Oct 11 (Reuters) - Vivus Inc said it would market its erectile dysfunction drug, Stendra, in the United States and Canada with Auxilium Pharmaceuticals Inc.

Auxilium said the deal, worth up to $300 million, would add to its earnings in 2015.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below